Mesothelioma, Malignant: all 418 studies
Page 3 of 5. Open to participants first (73), then studies with results posted, then the rest; newest registration first within each.
- Heated Intra-peritoneal Chemotherapy with Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric PatientsTerminatedNCT04213794Early Phase 1
- Pembrolizumab + Defactinib In Pleural MesotheliomaWithdrawnNCT04201145Phase 1
- Nivolumab with Chemotherapy in Pleural Mesothelioma After SurgeryCompletedNCT04177953Phase 2
- Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant MesotheliomaTerminatedNCT04173338Phase 1
- A Study of Nivolumab and Chemotherapy Followed by Surgery for MesotheliomaActive, not recruitingNCT04162015Phase 1
- Diadem to Investigate the Activity and Safety of DurvalumabCompletedNCT04115111Phase 2
- Mesothelioma Early Detection by VOCsTerminatedNCT04106973
- A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic MesotheliomaCompletedNCT04056026Early Phase 1
- Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in MesotheliomaCompletedNCT04040231Phase 1
- MTG201 Plus Nivolumab in Patients With Relapsed Pleural MesotheliomaStatus unknownNCT04013334Phase 2
- INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)WithdrawnNCT03920839Phase 1
- Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing CancerActive, not recruitingNCT03907852Phase 1/2
- Tazemetostat Expanded Access Program for Adults With Solid TumorsNo longer availableNCT03874455
- Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced TumoursStatus unknownNCT03852823Phase 1
- A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural MesotheliomaWithdrawnNCT03786419Phase 2
- Rehabilitation by Effort for Patients With Advanced Bronchial CancerTerminatedNCT03684486Not applicable
- Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing SurgeryCompletedNCT03678350Phase 1
- Dose Individualization of Pemetrexed - IMPROVE-ICompletedNCT03656549Phase 4
- Dose Individualization of Pemetrexed - IMPROVE-IIICompletedNCT03655834Phase 4
- Dose Individualization of Pemetrexed - IMPROVE-IITerminatedNCT03655821Phase 4
- DENdritic Cell Immunotherapy for MesotheliomaCompletedNCT03610360Phase 2/3
- Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal MesotheliomaTerminatedNCT03608618Phase 1
- A Double Blind, Placebo Controlled, Randomized Phase II Study Evaluating Gemcitabine With or Without Ramucirumab , for II Line Treatment MPMCompletedNCT03560973Phase 2
- IP3R Modulation by Cancer Genes in MesotheliomaStatus unknownNCT03558932
- Pembrolizumab Plus Autologous Dendritic Cell Vaccine in Patients with PD-L1 Negative Advanced Mesothelioma Who Have Failed Prior TherapiesActive, not recruitingNCT03546426Phase 1
- A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsCompletedNCT03517488Phase 1
- First-in-human Study of BAY2287411 Injection, a Thorium-227 Labeled Antibody-chelator Conjugate, in Patients With Tumors Known to Express MesothelinCompletedNCT03507452Phase 1
- Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsTerminatedNCT03420963Phase 1
- MesoTRAP: A Study Comparing Video-assisted Thoracoscopic Partial Pleurectomy/Decortication With Indwelling Pleural Catheter in Patients With Trapped Lung Due to Malignant Pleural Mesothelioma.CompletedNCT03412357Not applicable
- Combination of Immunotherapy and Hyperthermia in Advanced Malignant MesotheliomaTerminatedNCT03393858Phase 1/2
- Confocal Laser Endomicroscopy in Pleural MalignanciesStatus unknownNCT03290183
- Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural MesotheliomaActive, not recruitingNCT03269227Not applicable
- Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma.CompletedNCT03213301Phase 2
- Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced CancersActive, not recruitingNCT03212404Phase 1
- Clinical Study of YS110 in Patients With Malignant Pleural MesotheliomaCompletedNCT03177668Phase 1/2
- Atezolizumab and Bevacizumab in Treating Patients With Rare Solid TumorsActive, not recruitingNCT03074513Phase 2
- Malignant Mesothelioma - Can we Improve Quality of LifeCompletedNCT03068117Not applicable
- CheckpOiNt Blockade For Inhibition of Relapsed MesotheliomaCompletedNCT03063450Phase 3
- Ipilimumab and Nivolumab in the Treatment of Malignant Pleural MesotheliomaCompletedNCT03048474Phase 2
- Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by SurgeryActive, not recruitingNCT03007030Phase 2
- A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Coding Oncolytic Adenovirus, and Pemetrexed/Cisplatin in Patients With Unresectable Malignant Pleural MesotheliomaStatus unknownNCT02879669Phase 1/2
- Nintedanib as Switch Maintenance Treatment of Pleural Malignant MesotheliomaTerminatedNCT02863055Phase 2
- Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPMTerminatedNCT02838745Phase 1
- Genomic Analysis of Peritoneal Mesothelioma by CGH ArraysCompletedNCT02834234
- French National Registry of Rare Peritoneal Surface MalignanciesStatus unknownNCT02834169
- Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural MesotheliomaStatus unknownNCT02761863
- uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the LungStatus unknownNCT02755675Phase 2
- Nivolumab Monotherapy or Nivolumab Plus Ipilimumab, for Unresectable Malignant Pleural Mesothelioma (MPM) PatientsCompletedNCT02716272Phase 2
- A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural MesotheliomaTerminatedNCT02707666Phase 1
- Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural MesotheliomaCompletedNCT02662504Phase 2
- A Phase Ib Trial of a Maintenance Multipeptide Vaccine (S-588210) in Patients With Unresectable Malignant Pleural Mesothelioma Without Progression After First-Line ChemotherapyWithdrawnNCT02661659Phase 1
- Autologous Dendritic Cell Vaccination in MesotheliomaCompletedNCT02649829Phase 1/2
- Staging Procedures to Diagnose Malignant Pleural MesotheliomaTerminatedNCT02648763
- Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural MesotheliomaWithdrawnNCT02639767Phase 1
- A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549Status unknownNCT02637531Phase 1
- Chemotherapy Followed by Surgery and Neoadjuvant Hemothoracic Intensity Modified Radiation Therapy (IMRT) for Patients With Malignant Pleural MesotheliomaTerminatedNCT02613312
- Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)CompletedNCT02603315
- A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)Status unknownNCT02588131Phase 2
- Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-mesoStatus unknownNCT02580747Phase 1
- Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionWithdrawnNCT02567396Phase 1
- Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPMCompletedNCT02555007Phase 1
- 11C-Methionine PET/CT Imaging in Patients Affected by Malignant Pleural Mesothelioma (MPM)CompletedNCT02519049
- Comparison of Progel Sealant to Standard of Care (SOC) for Patients Undergoing DecorticationWithdrawnNCT02511600Phase 3
- Nivolumab in Patients With Recurrent Malignant MesotheliomaCompletedNCT02497508Phase 2
- Four Versus Six Cycles of Pemetrexed/Platinum for MPMStatus unknownNCT02497053Phase 2
- Isolated Thoracic Perfusion (ITP-F) for MPMCompletedNCT02467426
- Intrapleural Cryotherapy for Malignant Pleural MesotheliomaTerminatedNCT02464904Not applicable
- Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPMStatus unknownNCT02436733Phase 2
- TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma PatientsCompletedNCT02414945Phase 1/2
- Safety and Efficacy of TTFields (150 kHz) Concomitant With Pemetrexed and Cisplatin or Carboplatin in Malignant Pleural Mesothelioma (STELLAR)CompletedNCT02397928Phase 2
- Dendritic Cells Loaded With Allogeneous Cell Lysate in Mesothelioma PatientsStatus unknownNCT02395679Phase 1
- Screening of Alberta Asbestos Exposed Workers for Lung Cancer and MesotheliomaTerminatedNCT02385812Phase 2
- A Phase 1 Dose Escalation Study of VS-5584 Administered in Combination With VS-6063, in Subjects With Relapsed Malignant MesotheliomaTerminatedNCT02372227Phase 1
- MesomiR 1: A Phase I Study of TargomiRs as 2nd or 3rd Line Treatment for Patients With Recurrent MPM and NSCLCCompletedNCT02369198Phase 1
- Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural MesotheliomaCompletedNCT02303899Phase 2
- Observational Prospective Analysis of Biological Characteristics of Mesothelioma PatientsCompletedNCT02300883
- Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural MesotheliomaCompletedNCT02269878
- SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial AccessCompletedNCT02214134
- ATREUS - Phase II Study on the Activity of Trabectedin in Patients With Malignant Pleural Mesothelioma (MPM)CompletedNCT02194231Phase 2
- Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ MesotheliomaCompletedNCT02141347Phase 1
- Vinorelbine in MesotheliomaCompletedNCT02139904Phase 2
- Photodynamic Therapy During Surgery in Treating Patients With Pleural MalignancyWithdrawnNCT02106559Not applicable
- Study of the Combination of Tivantinib Plus Pemetrexed and CarboplatinCompletedNCT02049060Phase 1/2
- Mesothelioma and Radical Surgery 2Status unknownNCT02040272Not applicable
- Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and CisplatinTerminatedNCT02029690Phase 1
- Serum Biomarkers in Diagnosis of MesotheliomaCompletedNCT02029105
- Thromboelastography During Surgery for Malignant Pleural MesotheliomaStatus unknownNCT01912547
- Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung CancerTerminatedNCT01898156Phase 1/2
- Placebo Controlled Study of VS-6063 in Subjects With Malignant Pleural MesotheliomaTerminatedNCT01870609Phase 2
- Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural MesotheliomaStatus unknownNCT01869023Phase 2
- Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma PatientsCompletedNCT01865045
- Survival of Peritoneal Mesothelioma After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC)CompletedNCT01812148
- The ISET (Isolation by Size of Epithelial Tumor Cells) and the CellSearch Methods in Malignant Pleural MesotheliomaCompletedNCT01776385Not applicable
- Clinical and Histopathologic Characteristics of BAP1 MutationsCompletedNCT01773655
- A Phase II Study of Single-agent DOVitinib in Advanced Malignant PlEural Mesothelioma Which Has Progressed Following Prior Platinum-Antifolate ChemotherapyTerminatedNCT01769547Phase 2
- Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural MesotheliomaCompletedNCT01722149Early Phase 1
- Intrapleural Administration of HSV1716 to Treat Patients With Malignant Pleural Mesothelioma.CompletedNCT01721018Phase 1/2
- Early Detection of Lung Cancer and Mesothelioma in Workers Exposed to AsbestosStatus unknownNCT01719068
- The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant MesotheliomaStatus unknownNCT01655888Phase 2
- A Study of LY3023414 in Participants With Advanced CancerCompletedNCT01655225Phase 1